Sharpley Christopher F, Christie David R H
East Coast Cancer Centre, John Flynn Hospital, Gold Coast, Australia.
Psychooncology. 2007 Jul;16(7):660-7. doi: 10.1002/pon.1118.
Zung's Self-Rating Anxiety Scale and Self-Rating Depression Scale were used to collect data from 195 Australian men who had received a diagnosis of prostate cancer. Analysis was via separate scales and also by combining both scales into a single unit to assess anxiety-depression and then analysing the underlying component structure of that unit. Applying Zung's recommended cutoff scores, 12% of the sample were classified as having clinically significant levels of anxiety and 16% had similar levels of depression. Factor analysis of the combined SAS and SDS indicated four major components which reflected a process of: loss of functional capacity, worthlessness and hopelessness, fear and somatic symptomatology. Implications for the effective assessment and treatment of anxiety and depression in prostate patients are discussed.
采用zung自评焦虑量表和自评抑郁量表，对195名被诊断患有前列腺癌的澳大利亚男性进行数据收集。分析通过单独的量表进行，也通过将两个量表合并为一个单元来评估焦虑抑郁情况，然后分析该单元的潜在组成结构。应用zung推荐的临界值，12%的样本被归类为具有临床显著水平的焦虑，16%的样本具有相似水平的抑郁。对合并后的焦虑自评量表和抑郁自评量表进行因子分析，结果显示有四个主要成分，分别反映了以下过程：功能能力丧失、无价值感和绝望感、恐惧以及躯体症状。文中讨论了对前列腺癌患者焦虑和抑郁进行有效评估及治疗的意义。
